Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi’s Varicelliform Eruption

Kaposi’s varicelliform eruption (KVE) is a disseminated cutaneous infection usually induced by herpesvirus type 1 or 2, vaccinia virus or Coxsackie A16 virus in a patient with an underlying dermatosis. Risk factors for KVE reported in the literature include erythroderma, systemic sepsis, therapy wit...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in dermatology 2019-09, Vol.11 (Suppl 1), p.4-10
Main Authors: Campanati, Anna, Molinelli, Elisa, Brisigotti, Valerio , Brancorsini, Donatella, Bobyr, Ivan, Diotallevi, Federico, Radi, Giulia, Offidani, Annamaria
Format: Article
Language:English
Subjects:
Herpes simplex virus
Psoriasis
Secukinumab
Single Case
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Kaposi’s varicelliform eruption (KVE) is a disseminated cutaneous infection usually induced by herpesvirus type 1 or 2, vaccinia virus or Coxsackie A16 virus in a patient with an underlying dermatosis. Risk factors for KVE reported in the literature include erythroderma, systemic sepsis, therapy with immunosuppressants such as methotrexate and systemic steroids, and therapy with systemic retinoids. The occurrence of KVE in psoriasis is rare and it predominantly appears in patients affected by erythrodermic psoriasis during immunosuppressive treatment. We report our experience of a remarkable case of a patient affected by severe erythrodermic psoriasis and KVE that healed after antiviral treatment and after having received secukinumab. After 1 year, psoriasis was cleared and no recurrence of KVE had occurred.
ISSN:1662-6567
1662-6567
DOI:10.1159/000501992